Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease.
Journal: The New England journal of medicine
Published: April 03, 2026
RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report.
Journal: American journal of hematology
Published: September 25, 2025
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial.
Journal: American journal of hematology
Published: November 01, 2023
Anakinra utilization in refractory pediatric CAR T-cell associated toxicities.
Journal: Blood advances
Published: January 13, 2022
Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease.
Journal: The New England journal of medicine
Published: December 13, 2021
Outcomes Using Narrowband UVB Phototherapy for Acute Cutaneous Graft Versus Host Disease in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Journal: Journal of pediatric hematology/oncology
Published: December 14, 2020
Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: August 01, 2018
The effect of bone marrow graft composition on pediatric bone marrow transplantation outcomes.
Journal: Pediatric transplantation
Published: January 16, 2018
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.
Journal: Blood
Published: May 23, 2016
Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia.
Journal: Pediatric blood & cancer
Published: September 03, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026